These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20659284)

  • 21. Risk factors for gastrointestinal bleeding associated with low-dose aspirin.
    Valkhoff VE; Sturkenboom MC; Kuipers EJ
    Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):125-40. PubMed ID: 22542151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-steroidal anti-inflammatory drugs and Helicobacter pylori in upper gastrointestinal bleeding].
    Lee YC
    Korean J Gastroenterol; 2004 Sep; 44(3):172-6. PubMed ID: 15385727
    [No Abstract]   [Full Text] [Related]  

  • 24. Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users.
    Sostres C; Carrera-Lasfuentes P; Benito R; Roncales P; Arruebo M; Arroyo MT; Bujanda L; García-Rodríguez LA; Lanas A
    Am J Gastroenterol; 2015 May; 110(5):684-9. PubMed ID: 25895518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low dose aspirin, H. pylori infection, and the risk of upper gastrointestinal bleeding.
    Sostres C; Lanas A
    Med J Aust; 2018 Sep; 209(7):297-298. PubMed ID: 30257631
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases.
    Serrano P; Lanas A; Arroyo MT; Ferreira IJ
    Aliment Pharmacol Ther; 2002 Nov; 16(11):1945-53. PubMed ID: 12390104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
    Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
    Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding.
    Lanas A
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S37-42. PubMed ID: 10379468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of aspirin-induced gastroduodenal damage: H. pylori infection eradication versus proton pump inhibitors or both.
    Lanas A
    Dig Liver Dis; 2004 Oct; 36(10):655-7. PubMed ID: 15506662
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antithrombotic drug and gastrointestinal injuries].
    Kawai T; Fukuzawa M; Moriyasu F; Yamashina A
    Nihon Rinsho; 2013 Feb; 71(2):365-8. PubMed ID: 23631222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
    Chan FK
    Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].
    Nardulli G; Lanas A
    Gastroenterol Hepatol; 2009 Jan; 32(1):36-43. PubMed ID: 19174098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gastrointestinal bleeding associated with NSAIDs, antiplatelet therapy and anticoagulant agent].
    Lanas A
    Gastroenterol Hepatol; 2012 Sep; 35 Suppl 1():35-42. PubMed ID: 23018006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidences, temporal trends and risks of hospitalisation for gastrointestinal bleeding in new or chronic low-dose aspirin users after treatment for
    Guo CG; Cheung KS; Zhang F; Chan EW; Chen L; Wong IC; Leung WK
    Gut; 2020 Mar; 69(3):445-452. PubMed ID: 31101690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients.
    Chan HL; Wu JC; Chan FK; Choi CL; Ching JY; Lee YT; Leung WK; Lau JY; Chung SC; Sung JJ
    Gastrointest Endosc; 2001 Apr; 53(4):438-42. PubMed ID: 11275883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of H. pylori infection on upper gastrointestinal damage].
    Kawai T; Fukuzawa M; Moriyasu F; Yamashina A
    Nihon Rinsho; 2010 Nov; 68(11):2020-4. PubMed ID: 21061526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.
    Kang JM; Kim N; Lee BH; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Scand J Gastroenterol; 2011 Nov; 46(11):1295-301. PubMed ID: 21815866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. More favorable outcomes with peptic ulcer bleeding due to Helicobacter pylori.
    Chason RD; Reisch JS; Rockey DC
    Am J Med; 2013 Sep; 126(9):811-818.e1. PubMed ID: 23830535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics of Helicobacter pylori-negative drug-negative peptic ulcer bleeding.
    Chung WC; Jeon EJ; Kim DB; Sung HJ; Kim YJ; Lim ES; Kim MA; Oh JH
    World J Gastroenterol; 2015 Jul; 21(28):8636-43. PubMed ID: 26229405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.